Zhao X - Search Results

1

ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.

Fan W, Liu T, Chen W, Hammad S, Longerich T, Hausser I, Fu Y, Li N, He Y, Liu C, Zhang Y, Lian Q, Zhao X, Yan C, Li L, Yi C, Ling Z, Ma L, Zhao X, Xu H, Wang P, Cong M, You H, Liu Z, Wang Y, Chen J, Li D, Hui L, Dooley S, Hou J, Jia J, Sun B. Fan W, et al. Among authors: zhao x. Gastroenterology. 2019 Nov;157(5):1352-1367.e13. doi: 10.1053/j.gastro.2019.07.036. Epub 2019 Jul 27. Gastroenterology. 2019. PMID: 31362006 Free article.

2

Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis.

Tang W, Wang Y, Zhao X, Wang X, Zhang T, Ou X, Shou W, You H, Jia J. Tang W, et al. Among authors: zhao x. Eur J Gastroenterol Hepatol. 2015 Jun;27(6):672-8. doi: 10.1097/MEG.0000000000000352. Eur J Gastroenterol Hepatol. 2015. PMID: 25923942

3

Tanshinone IIA promotes the proliferation of WB-F344 hepatic oval cells via Wnt/β-catenin signaling.

Ze X, Jia J, Li X, You H, Zhao X, Zhang D, Wang B. Ze X, et al. Among authors: zhao x. Mol Med Rep. 2016 Feb;13(2):1501-8. doi: 10.3892/mmr.2015.4696. Epub 2015 Dec 18. Mol Med Rep. 2016. PMID: 26709094 Free PMC article.

4

Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up.

Zhang W, Wang X, Wang Y, Zhao X, Duan W, Wang Q, Wu X, Kong Y, Ma H, You H, Ou X, Jia J. Zhang W, et al. Among authors: zhao x. Medicine (Baltimore). 2017 Nov;96(44):e8454. doi: 10.1097/MD.0000000000008454. Medicine (Baltimore). 2017. PMID: 29095292 Free PMC article.

5

Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA.

Duan W, Ou X, Wang X, Wang Y, Zhao X, Wang Q, Wu X, Zhang W, Ma H, You H, Jia J. Duan W, et al. Among authors: zhao x. Rev Esp Enferm Dig. 2018 Sep;110(9):557-563. doi: 10.17235/reed.2018.5533/2018. Rev Esp Enferm Dig. 2018. PMID: 29739227 Free article.

6

Clinicopathological features of He Shou Wu-induced liver injury: This ancient anti-aging therapy is not liver-friendly.

Wang Y, Wang L, Saxena R, Wee A, Yang R, Tian Q, Zhang J, Zhao X, Jia J. Wang Y, et al. Among authors: zhao x. Liver Int. 2019 Feb;39(2):389-400. doi: 10.1111/liv.13939. Epub 2018 Aug 25. Liver Int. 2019. PMID: 30066422

7

Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants.

Lv T, Zhang W, Xu A, Li Y, Zhou D, Zhang B, Li X, Zhao X, Wang Y, Wang X, Duan W, Wang Q, Xu H, Zheng J, Zhao R, Zhu L, Dong Y, Lu L, Chen Y, Long J, Zheng S, Wang W, You H, Jia J, Ou X, Huang J. Lv T, et al. Among authors: zhao x, zhao r. J Med Genet. 2018 Oct;55(10):650-660. doi: 10.1136/jmedgenet-2018-105348. Epub 2018 Aug 30. J Med Genet. 2018. PMID: 30166352 Clinical Trial.

8

Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress.

Liu T, Wang P, Cong M, Zhao X, Zhang D, Xu H, Liu L, Jia J, You H. Liu T, et al. Among authors: zhao x. Br J Pharmacol. 2018 Dec;175(24):4480-4495. doi: 10.1111/bph.14503. Epub 2018 Oct 23. Br J Pharmacol. 2018. PMID: 30266038 Free PMC article.

9

Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from China.

Chen S, Duan W, Li M, Li S, Lv T, Tian Q, Wang Q, Wu X, Zhao X, Wang X, Wang Y, Kong Y, Ma H, Ou X, You H, Jia J. Chen S, et al. Among authors: zhao x. J Gastroenterol Hepatol. 2019 Jul;34(7):1236-1241. doi: 10.1111/jgh.14521. Epub 2018 Nov 14. J Gastroenterol Hepatol. 2019. PMID: 30365184

10

A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.

Zhang W, Xu A, Li Y, Zhao S, Zhou D, Wu L, Zhang B, Zhao X, Wang Y, Wang X, Duan W, Wang Q, Nan Y, You H, Jia J, Ou X, Huang J; China Registry of Genetic/Metabolic Liver Diseases (CR-GMLD) Group. Zhang W, et al. Among authors: zhao x, zhao s. Liver Int. 2019 Jun;39(6):1120-1127. doi: 10.1111/liv.14013. Epub 2018 Dec 28. Liver Int. 2019. PMID: 30500107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47,844 results

Search Page